Welcome to our dedicated page for Ingevity SEC filings (Ticker: NGVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingevity Corporation filings document formal disclosure for its specialty materials business, public-company governance, and capital structure. Form 8-K reports cover operating results, segment reporting presentation, credit agreement amendments, material agreements, and completed dispositions of North Charleston crude tall oil refinery assets and the majority of the Industrial Specialties product line.
Proxy and annual-meeting filings disclose director elections, board structure, executive compensation matters, shareholder voting results, and amendments to the company’s equity incentive plan. The filing record also includes disclosures tied to financing arrangements, continuing-operations measures, and governance matters affecting Ingevity’s common stock as a NYSE-listed issuer.
Ingevity Corporation reported the results of its annual stockholder meeting held on April 29, 2026. Stockholders approved an amendment to the Ingevity Corporation 2025 Omnibus Incentive Plan, increasing the number of shares available for issuance under the plan by 580,000 shares.
All nine director nominees were elected for one-year terms. Stockholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers and ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal 2026. A quorum was reached, with 33,498,332 of 35,222,538 entitled shares represented.
Ingevity Corp director Luis M. Fernandez-Moreno received an equity award of 1,904 shares of common stock on April 30, 2026. The award was granted as restricted stock units under Ingevity Corporation's 2025 Omnibus Incentive Plan and carries no cash exercise price.
The restricted stock units will vest in full on April 30, 2027, meaning the director must remain eligible through that date to receive the shares outright. Following this compensation-related grant, Fernandez-Moreno directly holds 37,882 shares of Ingevity common stock as reported in this filing.
Gulyas Diane H. reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp director Diane H. Gulyas received 1,904 shares of common stock as a grant of restricted stock units. The award was granted at a price of $0.00 per share under Ingevity Corporation's 2025 Omnibus Incentive Plan and will vest in full on April 30, 2027.
Following this grant, she holds 14,788 shares of Ingevity common stock directly. Separately, 3,747 shares are held indirectly through the Diane H. Gulyas Trust, where she serves as trustee and her spouse is the beneficiary.
Ingevity Corp director Bruce D. Hoechner received a grant of 1,904 deferred stock units (DSUs) of Common Stock as equity compensation. The award was made in lieu of the annual non-employee director restricted stock unit grant and carries no cash exercise price.
The DSUs will vest on April 30, 2027 and will convert into an equal number of Ingevity Common Stock shares when his board service ends, under the company’s Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. Following this grant, Hoechner directly holds 10,732 shares.
Lynch Frederick J reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp director Frederick J. Lynch reported a compensation-related equity award. He received 1,904 restricted stock units of Ingevity common stock at no purchase price under the company’s 2025 Omnibus Incentive Plan. These units will vest in full on April 30, 2027, bringing his direct holdings to 28,263 shares after the grant.
NARWOLD KAREN G reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp director receives equity award through a grant of 1,904 shares of common stock to Karen G. Narwold. The grant is reported at a price of $0.00 per share as a compensation-related award, not an open-market purchase, and increases her direct holdings to 18,900 shares.
The award represents restricted stock units granted under Ingevity Corporation's 2025 Omnibus Incentive Plan and is scheduled to vest in full on April 30, 2027. This filing records a routine equity-based compensation grant rather than a discretionary stock trade.
Segal Francis David reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp director Francis David Segal reported receiving an equity award under the company’s 2025 Omnibus Incentive Plan. He was granted 1,904 shares of Common Stock at no cost, structured as restricted stock units that will vest in full on April 30, 2027. Following this grant, he directly holds 8,284 shares of Ingevity common stock.
Ingevity Corp director Kevin J. Willis received an equity award of 1,904 deferred stock units. The grant reflects his election to take deferred stock units instead of the usual annual restricted stock unit grant for non-employee directors.
The deferred stock units will vest on April 30, 2027 and will convert into an equal number of Ingevity common shares when his board service ends, under the company’s Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. After this award, he holds 11,081 shares directly.
Ingevity director Benjamin G. Wright received an equity grant in the form of deferred stock units. He was granted 1,904 deferred stock units in lieu of the annual non-employee director restricted stock unit grant, at no cash cost per unit. These units will vest on April 30, 2027 and will convert into the same number of Ingevity common shares after his board service ends, under the company’s Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. Following this grant, he directly holds 11,948 shares.
Ingevity Corp reported that Vanguard Capital Management holds 1,853,415 shares of Common Stock, representing 5.26% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 1,853,415 shares and sole voting power over 271,544 shares. The submission describes ownership held by Vanguard Capital Management LLC and affiliates, including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd., and was signed by Ashley Grim on 04/30/2026.